astrazeneca glp 1 Latin America Glucagon-like Peptide-1 Agonists Market - GLP-1 AstraZeneca's Bydureon gets a facelift,

The market benefits from robust direct-to-consumer marketing efforts that drive patient demand and consultation rates

Novo Nordisk's incretin therapies Ozempic/Wegovy stand amongst the biggest breakthroughs in the history of the industry

This can help patients feel more confident about making lifestyle changes particularly dietary changes that play an important role in weight management. Monitoring and follow-up with a healthcare provider While on any of these drugs, you'll need regular monitoring from your provider

Horowitz M, Harding PE, Maddox AF, et al

GLP-1 is vital in reducing food intake (1, 2)

We work closely with patients to determine the appropriate insulin therapy, ensuring that it complements their lifestyle and health needs